Park Ha Biological Technology Co., Ltd.
Datakwaliteit: 100%
BYAH
Nasdaq
Manufacturing
Chemicals
€ 1,04
▼
€ 0,01
(-0,95%)
Marktkapitalisatie: 3,38 M
Prijs
€ 1,05
Marktkapitalisatie
3,38 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Earnings declined -5191,25% over the past year
Generating 85.852,0 in free cash flow
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)6,00%
Earnings (1Y)-5191,25%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-885,84%
Onder sectorgemiddelde (-53,53%)
ROIC-677,76%
Net Margin-965,00%
Op. Margin-956,45%
Veiligheid
Debt / Equity
N/A
Current Ratio3,68
Interest Coverage-588997,59
Waardering
PE (TTM)
-0,14
Boven sectorgemiddelde (-1,48)
P/B Ratio0,80
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1366 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1366 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,1 | -1,5 |
| P/B | 0,8 | 1,6 |
| ROE % | -885,8 | -53,5 |
| Net Margin % | -965,0 | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2026 | — | 2,68 M | — |
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | -5191,25% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,52 M | Net Income (TTM) | -24,36 M |
| ROE | -885,84% | ROA | -539,29% |
| Gross Margin | 94,36% | Operating Margin | -956,45% |
| Net Margin | -965,00% | Free Cash Flow (TTM) | 85.852,0 |
| ROIC | -677,76% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 3,68 |
| Interest Coverage | -588997,59 | Asset Turnover | 0,56 |
| Working Capital | 4,07 M | Tangible Book Value | 4,24 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,14 | Forward P/E | N/A |
| P/B Ratio | 0,80 | P/S Ratio | 1,34 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 2,54% | ||
| Market Cap | 3,38 M | Enterprise Value | 3,38 M |
| Per Share | |||
| EPS (Diluted TTM) | -41,38 | Revenue / Share | 0,78 |
| FCF / Share | 0,03 | OCF / Share | 0,03 |
| EPS CAGR (1Y) | -207000,00% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | -0,35% |
| SBC-Adj. FCF | -23,98 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | 2,52 M | 2,38 M |
| Net Income | -24,36 M | 478.561,0 |
| EPS (Diluted) | -41,38 | 0,02 |
| Gross Profit | 2,38 M | 2,19 M |
| Operating Income | -24,15 M | 793.714,0 |
| EBITDA | — | — |
| R&D Expenses | 238.184,0 | 36.714,0 |
| SG&A Expenses | — | — |
| D&A | 109.369,0 | 22.686,0 |
| Interest Expense | 41,0 | 194,0 |
| Income Tax | 280.646,0 | 314.860,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 5,95 M | 3,08 M |
| Total Liabilities | 1,96 M | 1,58 M |
| Shareholders' Equity | 3,99 M | 1,51 M |
| Total Debt | — | — |
| Cash & Equivalents | 3,79 M | 547.498,0 |
| Current Assets | 5,50 M | 2,84 M |
| Current Liabilities | 1,88 M | 1,52 M |
{"event":"ticker_viewed","properties":{"ticker":"BYAH","listing_kind":"stock","pathname":"/stocks/byah","exchange":"Nasdaq","country":"US"}}